Gil M. Labrucherie, SVP & Chief Financial Officer at NEKTAR THERAPEUTICS (NKTR), sold 25,000 shares at $17.79 ($445K) on 2019-08-14, disclosed to the SEC on 2019-08-16.
Seasonal sale ($445k) by SVP & Chief Financial Officer — this insider has traded NKTR in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |